Heart transplant warning: could a simple virus test spot rejection early?

NCT ID NCT05064462

Completed Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 60 heart transplant patients for one year to see if levels of a harmless virus called TTV in the blood are linked to infections or organ rejection. Researchers took monthly blood samples alongside routine care. The goal is to find a new way to monitor transplant health without extra procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors monitor heart transplant patients more closely and catch problems like infection or rejection earlier.
What could go wrong: This is an observational study, not a treatment trial. It only looks for a link between TTV levels and outcomes, so it cannot prove cause and effect. The results may not apply to all transplant patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Infections Rejection, Psychology transplant rejection trichorhinophalangeal syndrome type II viral infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART TRANSPLANT INFECTION HEART TRANSPLANT REJECTION VIRUS

Contacts and locations

Locations

CHU Strasbourg

Strasbourg, 67091, France
CHU de Rennes

Rennes, 35033, France
Hôpital européen Georges Pompidou

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.